About: COVID-19 Diagnostics, Tools, and Prevention

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 Diagnostics, Tools, and Prevention Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	COVID-19 Diagnostics, Tools, and Prevention
Creator	Song, Zexing Allam, Mayar Cai, Shuangyi Coskun, Ahmet Doodhwala, Saurabh Ganesh, Shambavi Heit, Jeremy Hu, Thomas Kumar, Aditi Study Group, Covid-19 Venkatesan, Mythreye
source	Medline; PMC
abstract	The Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), outbreak from Wuhan City, Hubei province, China in 2019 has become an ongoing global health emergency. The emerging virus, SARS-CoV-2, causes coughing, fever, muscle ache, and shortness of breath or dyspnea in symptomatic patients. The pathogenic particles that are generated by coughing and sneezing remain suspended in the air or attach to a surface to facilitate transmission in an aerosol form. This review focuses on the recent trends in pandemic biology, diagnostics methods, prevention tools, and policies for COVID-19 management. To meet the growing demand for medical supplies during the COVID-19 era, a variety of personal protective equipment (PPE) and ventilators have been developed using do-it-yourself (DIY) manufacturing. COVID-19 diagnosis and the prediction of virus transmission are analyzed by machine learning algorithms, simulations, and digital monitoring. Until the discovery of a clinically approved vaccine for COVID-19, pandemics remain a public concern. Therefore, technological developments, biomedical research, and policy development are needed to decipher the coronavirus mechanism and epidemiological characteristics, prevent transmission, and develop therapeutic drugs.
has issue date	2020-06-16(xsd:dateTime)
bibo:doi	10.3390/diagnostics10060409
bibo:pmid	32560091
has license	cc-by
sha1sum (hex)	7ac64aaf35877e3f165b88a5ff30766047a69952
schema:url	https://doi.org/10.3390/diagnostics10060409
resource representing a document's title	COVID-19 Diagnostics, Tools, and Prevention
has PubMed Central identifier	PMC7344926
has PubMed identifier	32560091
schema:publication	Diagnostics (Basel)
resource representing a document's body	covid:7ac64aaf35877e3f165b88a5ff30766047a69952#body_text
is schema:about of	named entity 'China' named entity 'shortness' named entity 'patients' named entity 'virus' named entity 'Disease' named entity 'Therefore' named entity 'decipher' named entity 'global health' named entity 'Diagnostics' named entity 'COUGHING' named entity 'APPROVED' named entity 'DEVELOPMENTS' named entity 'PREVENT' named entity 'MUSCLE ACHE' named entity 'CORONAVIRUS' named entity 'DECIPHER' named entity 'pathogenic' named entity 'suspended' named entity 'epidemiological' named entity 'Hubei' named entity '19 management' named entity 'City' named entity 'breath' named entity 'develop' named entity 'generated' named entity 'coronavirus' named entity 'COVID' named entity 'muscle ache' named entity 'pandemics' named entity 'therapeutic drugs' named entity 'coronavirus' named entity 'vaccine' named entity 'medical supplies' named entity 'sneezing' named entity 'COVID-19' named entity 'transmission' named entity 'healthcare sector' named entity 'peer-reviewed' named entity 'influenza virus' named entity 'cellular receptors' named entity 'antibody' named entity 'SARS-CoV-2' named entity 'ADE' named entity 'RT-PCR' named entity 'viral particles' named entity 'spike protein' named entity 'COVID' named entity 'QR code' named entity 'API' named entity 'Ebola' named entity 'Wuhan' named entity 'vaccine' named entity 'protein' named entity 'Healthcare professionals' named entity 'COVID' named entity 'N95' named entity 'muscle ache' named entity 'SARS-CoV-2' named entity 'lung' named entity 'sterilization' named entity 'infection rate' named entity 'Remdesivir' named entity 'medical professionals' named entity 'SARS-CoV-2' named entity 'respiratory droplets' named entity 'Inovio Pharmaceuticals' named entity 'FDA' named entity 'evolution' named entity 'personal protection' named entity 'herd immunity' named entity 'prevent the spread'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software